TY  - GEN
AU  - Dong,Shu-Jie
AU  - Wu,Bin
AU  - Zhai,Suo-Di
AU  - Zhang,Yan-Jun
AU  - Chu,Yun-Bo
AU  - Gupta,Parul
AU  - Li,Ya-Huei
TI  - Cost-effectiveness of Dabigatran Compared With Rivaroxaban for Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in China
SN  - 1879-114X
PY  - 2020///0918
KW  - Aged
KW  - Anticoagulants
KW  - economics
KW  - Atrial Fibrillation
KW  - drug therapy
KW  - China
KW  - Cost-Benefit Analysis
KW  - Dabigatran
KW  - Embolism
KW  - prevention & control
KW  - Female
KW  - Humans
KW  - Male
KW  - Markov Chains
KW  - Models, Economic
KW  - Quality-Adjusted Life Years
KW  - Rivaroxaban
KW  - Stroke
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.clinthera.2019.11.011
ER  -